Publication Information

{'id': 'https://openalex.org/W2076236146', 'doi': 'https://doi.org/10.1200/jco.2009.26.2121', 'title': 'Accelerated Approval and Oncology Drug Development Timelines', 'display_name': 'Accelerated Approval and Oncology Drug Development Timelines', 'publication_year': 2010, 'publication_date': '2010-03-02', 'ids': {'openalex': 'https://openalex.org/W2076236146', 'doi': 'https://doi.org/10.1200/jco.2009.26.2121', 'mag': '2076236146', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/20194846'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1200/jco.2009.26.2121', 'pdf_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.26.2121?role=tab', 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.26.2121?role=tab', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052998210', 'display_name': 'Michael Lanthier', 'orcid': 'https://orcid.org/0000-0001-9673-2852'}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael L. Lanthier', 'raw_affiliation_strings': ['Office of Planning, Office of the Commissioner, US Food and Drug Administration, Rockville, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Planning, Office of the Commissioner, US Food and Drug Administration, Rockville, MD', 'institution_ids': ['https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110134625', 'display_name': 'Rajeshwari Sridhara', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rajeshwari Sridhara', 'raw_affiliation_strings': ['Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070547422', 'display_name': 'John R. Johnson', 'orcid': 'https://orcid.org/0000-0002-3920-9923'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John R. Johnson', 'raw_affiliation_strings': ['Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078022350', 'display_name': 'Ann T. Farrell', 'orcid': 'https://orcid.org/0000-0001-8477-3972'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ann Farrell', 'raw_affiliation_strings': ['Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077268765', 'display_name': 'Patricia Keegan', 'orcid': 'https://orcid.org/0000-0002-7266-395X'}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Patricia Keegan', 'raw_affiliation_strings': ['Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040994580', 'display_name': 'Robert Justice', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert Justice', 'raw_affiliation_strings': ['Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5051520990', 'display_name': 'Richard Pazdur', 'orcid': 'https://orcid.org/0000-0002-4771-9923'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Pazdur', 'raw_affiliation_strings': ['Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD'], 'affiliations': [{'raw_affiliation_string': 'Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.686747, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '28', 'issue': '14', 'first_page': 'e226', 'last_page': 'e227'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9967, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10804', 'display_name': 'Health Systems, Economic Evaluations, Quality of Life', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T13656', 'display_name': 'Science, Research, and Medicine', 'score': 0.988, 'subfield': {'id': 'https://openalex.org/subfields/2743', 'display_name': 'Reproductive Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/drug-development', 'display_name': 'Drug Development', 'score': 0.63924}, {'id': 'https://openalex.org/keywords/drug-approval', 'display_name': 'Drug approval', 'score': 0.544379}, {'id': 'https://openalex.org/keywords/timeline', 'display_name': 'Time line', 'score': 0.49457833}, {'id': 'https://openalex.org/keywords/clinical-oncology', 'display_name': 'Clinical Oncology', 'score': 0.46607825}, {'id': 'https://openalex.org/keywords/precision-oncology', 'display_name': 'Precision oncology', 'score': 0.43410024}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8795762}, {'id': 'https://openalex.org/C64903051', 'wikidata': 'https://www.wikidata.org/wiki/Q2198549', 'display_name': 'Drug development', 'level': 3, 'score': 0.63924}, {'id': 'https://openalex.org/C2992293740', 'wikidata': 'https://www.wikidata.org/wiki/Q4781752', 'display_name': 'Drug approval', 'level': 3, 'score': 0.544379}, {'id': 'https://openalex.org/C4438859', 'wikidata': 'https://www.wikidata.org/wiki/Q186117', 'display_name': 'Timeline', 'level': 2, 'score': 0.49457833}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.49040914}, {'id': 'https://openalex.org/C2776598537', 'wikidata': 'https://www.wikidata.org/wiki/Q1812651', 'display_name': 'Clinical Oncology', 'level': 3, 'score': 0.46607825}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.4422655}, {'id': 'https://openalex.org/C3020497934', 'wikidata': 'https://www.wikidata.org/wiki/Q17075943', 'display_name': 'Precision oncology', 'level': 3, 'score': 0.43410024}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.41764766}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.30490404}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.29484433}, {'id': 'https://openalex.org/C166957645', 'wikidata': 'https://www.wikidata.org/wiki/Q23498', 'display_name': 'Archaeology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C95457728', 'wikidata': 'https://www.wikidata.org/wiki/Q309', 'display_name': 'History', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': False}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': False}, {'descriptor_ui': 'D023381', 'descriptor_name': 'Endpoint Determination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D033161', 'descriptor_name': 'Government Regulation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013997', 'descriptor_name': 'Time Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': 'Q000331', 'qualifier_name': 'legislation & jurisprudence', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1200/jco.2009.26.2121', 'pdf_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.26.2121?role=tab', 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/20194846', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1200/jco.2009.26.2121', 'pdf_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.26.2121?role=tab', 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.4, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 3, 'referenced_works': ['https://openalex.org/W2082457815', 'https://openalex.org/W2101073224', 'https://openalex.org/W2104389711'], 'related_works': ['https://openalex.org/W96956006', 'https://openalex.org/W4361026857', 'https://openalex.org/W3165404536', 'https://openalex.org/W3010700640', 'https://openalex.org/W2338367129', 'https://openalex.org/W2171223526', 'https://openalex.org/W2036983269', 'https://openalex.org/W2034858584', 'https://openalex.org/W2029342376', 'https://openalex.org/W1502809559'], 'abstract_inverted_index': {'Richey': [0, 165], 'et': [1, 166], 'al': [2], '1': [3, 139], 'report': [4], 'that': [5, 54, 61, 95, 116, 196, 246, 323, 374], 'novel': [6, 382], 'oncology': [7, 77, 89], 'drugs': [8, 53, 78, 90, 383, 449], 'and': [9, 20, 179, 191, 230, 235, 241, 300, 349, 363, 384, 388, 398, 413, 421, 454], 'biologics': [10, 43, 385], '(new': [11], 'molecular': [12], 'entities': [13], '[NMEs])': [14], 'approved': [15, 199, 248, 440], 'through': [16, 441], 'the': [17, 48, 62, 83, 96, 111, 124, 151, 156, 159, 186, 209, 216, 261, 296, 314, 324, 333, 335, 360, 370, 375, 409, 418, 442, 448, 457, 459], 'US': [18], 'Food': [19], 'Drug': [21], "Administration's": [22], 'accelerated': [23], 'approval': [24, 57, 74, 174, 217, 263, 294, 329], '(AA)': [25], 'pathway': [26, 445], '(21': [27], 'CFR': [28, 38], '314.510': [29], '[Subpart': [30, 40], 'H]': [31], 'for': [32, 42, 75, 87, 243, 267, 295, 313, 327, 379, 381, 411, 425], 'new': [33, 68, 108], 'drug': [34, 69, 73, 136, 181, 259, 282, 312, 336], 'applications': [35, 45], '[NDAs],': [36], '21': [37], '601.41': [39], 'E]': [41], 'license': [44], '[BLAs])': [46], 'reach': [47], 'market': [49, 112], 'no': [50], 'faster': [51], 'than': [52], 'receive': [55, 279], 'regular': [56], '(RA).The': [58], 'authors': [59, 114, 194, 210, 224, 253, 303, 320, 419], 'state': [60, 195, 322], 'median': [63, 84, 376], 'development': [64, 85, 137, 366, 377], 'time': [65, 86], 'from': [66, 355], 'investigational': [67], 'application': [70, 204, 326], '(IND)': [71], 'to': [72, 110, 120, 134, 153, 306, 343, 352, 395, 403], 'AA': [76, 97, 229, 240, 387], 'was': [79, 91, 198, 330], '7.3': [80], 'years,': [81, 436], 'whereas': [82], 'RA': [88, 242, 389], '7.2': [92, 435], 'years.They': [93], 'conclude': [94], 'program': [98], 'does': [99], 'not': [100, 278], 'meet': [101], 'its': [102], 'intended': [103], 'purpose': [104], 'of': [105, 123, 147, 158, 161, 173, 188, 269, 298, 316, 447, 456], 'bringing': [106], 'important': [107], 'therapies': [109], 'sooner.The': [113], 'acknowledge': [115], 'they': [117], 'were': [118, 132, 247, 390], 'unable': [119], 'obtain': [121], '25%': [122], 'IND': [125, 365], 'filing': [126], 'dates,': [127], 'which': [128, 168], 'according': [129], 'their': [130, 423], 'definitions': [131], 'used': [133], 'calculate': [135], 'time.': [138], 'In': [140], 'our': [141], 'experience,': [142], 'such': [143, 189], 'a': [144, 291], 'high': [145], 'level': [146], 'missing': [148, 368], 'data': [149, 452], 'has': [150], 'potential': [152], 'substantively': [154], 'affect': [155, 185], 'outcome': [157, 187], 'type': [160], 'analysis': [162], 'conducted': [163], 'by': [164, 332], 'al.Inaccuracies,': [167], 'we': [169, 372, 407], 'identify': [170, 307], 'regarding': [171], 'classification': [172], 'status': [175], '(AA': [176], 'or': [177], 'RA)': [178], 'orphan': [180, 258, 281, 293, 311], 'designations,': [182], 'also': [183, 304], 'may': [184], 'analyses': [190], 'resultant': [192], 'conclusions.The': [193], 'tositumomab': [197], 'under': [200, 249, 339], 'AA;': [201], 'however,': [202], 'this': [203, 451], 'received': [205, 238, 290, 348], 'RA.': [206], '2': [207], 'Although': [208], 'classify': [211, 225], 'bicalutimide': [212], 'as': [213, 227, 232, 256, 309, 417], 'an': [214, 228, 233, 257, 280, 310], 'RA,': [215], 'letter': [218], 'clearly': [219], 'references': [220], 'AA.': [221], '2,3': [222], 'The': [223], 'sunitinib': [226, 412], 'dasatinib': [231, 236, 414], 'RA.Sunitinib': [234], 'simultaneously': [237], 'both': [239], 'different': [244], 'indications': [245], 'separate': [250], 'NDA': [251, 443], 'applications.The': [252], 'include': [254], 'cetuximab': [255, 289], 'approval;': [260], 'original': [262], 'in': [264, 286, 369, 450], 'February': [265], '2004': [266], 'treatment': [268, 297, 315, 356], 'epidermal': [270], 'growth': [271], 'factor': [272], 'receptor-expressing': [273], 'metastatic': [274], 'colorectal': [275], 'carcinoma': [276], 'did': [277], 'designation.Two': [283], 'years': [284, 392, 400], 'later,': [285], 'March': [287], '2006,': [288], 'supplemental': [292], 'head': [299], 'neck': [301], 'cancer.The': [302], 'failed': [305], 'azacitidine': [308], 'myelodysplastic': [317], 'syndromes.': [318], '4he': [319], 'incorrectly': [321], 'gefitinib': [325], 'marketing': [328], 'withdrawn': [331], 'sponsor;': [334], 'remains': [337], 'available': [338], 'restricted': [340], 'distribution': [341], 'provisions': [342], 'patients': [344], 'who': [345], 'have': [346], 'previously': [347], 'are': [350, 431], 'believed': [351], 'be': [353], 'benefitting': [354], 'with': [357], 'gefitinib.After': [358], 'correcting': [359], 'noted': [361], 'inaccuracies': [362], 'including': [364], 'times': [367, 378], 'publication,': [371], 'found': [373], 'NMEs': [380, 439], 'receiving': [386], '6.1': [391], '(range,': [393, 401], '3.1': [394], '12.4': [396], 'years)': [397], '7.1': [399], '3.0': [402], '33.4': [404], 'years),': [405], 'respectively.If': [406], 'count': [408], 'approvals': [410], 'only': [415], 'once': [416], 'did,': [420], 'accept': [422], 'designations': [424], 'these': [426], 'two': [427], 'drugs,': [428], 'similar': [429], 'results': [430], 'observed': [432], '(6.3': [433], 'v': [434], 'respectively).For': [437], 'nonbiologic': [438], 'regulatory': [444], '(82%': [446], 'set,': [453], '75%': [455], 'AAs),': [458], 'difference': [460], 'between': [461]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2076236146', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-12T23:19:00.952660', 'created_date': '2016-06-24'}